Hot Value Stocks To Own For 2021

Gold has been a store of value for millennia, and even now, many investors see gold as the ultimate safe haven asset. Yet recently, another precious metal became more valuable than gold — and it’s not the one you might expect.

For a long time, gold and platinum have battled it out for supremacy atop the precious metals markets. Since the 1970s, platinum has usually been worth more than gold, only occasionally dropping beneath the yellow metal’s price for short periods of time. Yet over the past few years, gold prices have surpassed platinum’s, and recently, the price disparity widened to more than $500 before narrowing slightly in the past couple of weeks.

Now, though, a new player has taken over the top spot. Palladium prices have more than doubled since the end of 2016 and are up almost 25% in just the first two months of 2019. That’s sent the rare metal’s price above gold’s for the first time ever.

Data source: Macrotrends. Chart by author.

Hot Value Stocks To Own For 2021: MakeMyTrip Limited(MMYT)

MakeMyTrip Limited, an online travel company, provides travel products and solutions in India and the United States. Its products and services include air tickets, hotels, packages, rail tickets, bus tickets, car hire, and ancillary travel requirements, such as travel insurance and visa processing. The company, through its Website,, allow travelers to research, plan, and book a range of travel services and products in India and internationally. MakeMyTrip Limited also provides its products and services through other technology-enhanced distribution channels, such as call centers, travel stores, and travel agents? network. Its customers comprise leisure travelers and small businesses. The company was formerly known as International Web Travel Private Limited and changed its name to MakeMyTrip Limited in April 2010. MakeMyTrip Limited was founded in 2000 and is based in Gurgaon, India.

Advisors’ Opinion:

  • [By Logan Wallace]

    MakeMyTrip (NASDAQ:MMYT) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday.

  • [By Max Byerly]

    TheStreet lowered shares of MakeMyTrip (NASDAQ:MMYT) from a c- rating to a d+ rating in a report published on Tuesday.

    Other equities research analysts also recently issued reports about the stock. Jefferies Financial Group raised shares of MakeMyTrip from a hold rating to a buy rating and set a $19.80 price target for the company in a research note on Wednesday, August 15th. BidaskClub downgraded shares of MakeMyTrip from a strong-buy rating to a buy rating in a research note on Wednesday, June 20th. Zacks Investment Research raised shares of MakeMyTrip from a hold rating to a buy rating and set a $45.00 price target for the company in a research note on Friday, June 15th. Bank of America dropped their price target on shares of MakeMyTrip from $40.00 to $39.50 and set a buy rating for the company in a research note on Monday, July 9th. Finally, ValuEngine downgraded shares of MakeMyTrip from a buy rating to a hold rating in a research note on Thursday, September 6th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $36.36.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MakeMyTrip (MMYT)

    For more information about research offerings from Zacks Investment Research, visit

Hot Value Stocks To Own For 2021: TTM Technologies, Inc.(TTMI)

TTM Technologies, Inc., incorporated on June 21, 2005, is a manufacturer of printed circuit board (PCB) products and is focused on technologically advanced PCBs and electro-mechanical solutions (E-M Solutions). The Company operates approximately 30 specialized facilities in the United States, the People’s Republic of China (China), Canada and Mexico. The Company’s operating segments include PCB, which consists of approximately 15 domestic PCB fabrication plants, including a facility that provides follow-on value-added services primarily for one of the PCB fabrication plants; over eight PCB fabrication plants in China and one in Canada, and E-M Solutions, which consists of approximately four custom electronic assembly plants; over three in China and one in Mexico. The Company serves a range of customer base in various markets, including manufacturers of networking/communications infrastructure products, smartphones and touchscreen tablets, as well as the aerospace and defense, computing and industrial/medical industries. Its customers include both original equipment manufacturers (OEMs) and electronic manufacturing services (EMS) providers. The Company offers a range of PCB products, including high density interconnect (HDI) PCBs, conventional PCBs, flexible PCBs, rigid-flex PCBs, backplane assemblies and integrated circuits (IC) substrates. It also offers certain services to support its customers’ needs, which include design for manufacturability (DFM) support during new product introduction stages; PCB layout design; simulation and testing services; QTA production, and drilling and routing services.

The Company is focused on high layer count conventional PCBs. A multi-layer PCB can accommodate complex circuitry than a single-sided or double-sided PCB and as such requires more production techniques. The Company’s North America and Asia Pacific operating segments produce HDI PCBs. HDI PCBs are boards with characteristics, including micro-sized holes, or microvias (diameter at or less than ! 0.15 millimeter (mm)), fine lines (circuit line width and spacing at or less than 0.075 mm) and can be constructed with thin high performance materials, thereby enabling interconnection functions per unit area. HDI PCBs generally are manufactured using a sequential build-up process in which circuitry is formed in the PCB one layer at a time through successive drilling, plating and lamination cycles. The Company manufactures circuits on flexible substrates that can be installed in three-dimensional applications for electronic packaging systems. Rigid-flex circuitry provides a means to integrate multiple PCB assemblies and other elements, such as display, input or storage devices without wires, cables or connectors, replacing them with thin, light composites that integrate wiring in ultra-thin, flexible ribbons between sections

The Company assembles backplanes and sub-systems and provides system integration of backplane assemblies, cabling, power, thermal and other complex electromechanical parts into chassis and other enclosures. In addition to assembly services, it provides inspection and testing services, such as automated optical inspection (AOI) and X-ray inspection to ensure that all components have been properly placed and electrical circuits are complete. IC substrates are mounts that are used to connect small ICs to comparatively PCBs for assembly into electronic end products, such as memory modules, cellular phones, digital cameras, automotive global positioning system (GPS) and engine controls. The Company produces and tests circuits used in radio-frequency or microwave emission and collection applications. These products are typically used for radar, transmit/receive antennas and similar wireless applications. The Company also provides custom-fabricated PCBs to customers within 24 hours to 10 days.

The Company competes with Chin Poon Industrial Co., LTD., Unimicron Technology Corp., IBIDEN Co., Ltd., Compeq Manufacturing Co., Ltd., Tripod Technology Corp., ISU Petasys! Co., Ltd! ., Sanmina Corporation, Multek Corporation, Wus Printed Circuit Co., Ltd., Flex, Jabil Circuit, Inc., AT & S Austria Technologie & Systemtechnik AG and Amphenol Corp.

Advisors’ Opinion:

  • [By Ethan Ryder]

    ILLEGAL ACTIVITY WARNING: “Miles Capital Inc. Acquires Shares of 10,416 TTM Technologies, Inc. (TTMI)” was originally published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at

  • [By Ethan Ryder]

    TTM Technologies (NASDAQ:TTMI) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Monday.

Hot Value Stocks To Own For 2021: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors’ Opinion:

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) has a PDUFA action date set for October 5 for its Jemdel (halobetasol propionate 0.01%) (IDP-122) lotion. If approved, Jemdel will be the first high-potency topical steroid treatment for plaque psoriasis with dosing for as long as eight weeks.

  • [By Shane Hupp]

    Korea Investment CORP cut its position in shares of Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 46.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,736 shares of the specialty pharmaceutical company’s stock after selling 109,300 shares during the quarter. Korea Investment CORP’s holdings in Valeant Pharmaceuticals were worth $2,948,000 at the end of the most recent reporting period.

Hot Value Stocks To Own For 2021: Magellan Health Services Inc.(MGLN)

Magellan Health Services, Inc. engages in the specialty managed healthcare business in the United States. The company, through its contracted network of third-party treatment providers, offers managed behavioral healthcare services, including outpatient programs, such as counseling or therapy; intermediate care programs comprising intensive outpatient programs and partial hospitalization services; and inpatient treatment and crisis intervention services. It also provides radiology benefits management services, such as the delivery of diagnostic imaging and other therapeutic services through contracts with health plans and insurance companies, and governmental agencies. In addition, the company offers specialty pharmaceutical management services, including contracting and formulary optimization programs; specialty pharmaceutical dispensing operations; and medical pharmacy management programs. Its specialty pharmaceutical management services are provided under contracts with health plans, insurance companies, employers, and governmental agencies to manage specialty drugs used in the treatment of conditions, such as cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis, and other diseases. Further, the company provides Medicaid administration services comprising pharmacy point-of-sale claims processing systems and administration, drug utilization review, clinical prior authorization, utilization and formulary management services, preferred drug list programs, maximum allowable cost programs, and drug rebate program services under contracts with health plans and public sector healthcare clients for Medicaid and other program recipients. It serves health plans, insurance companies, employers, labor unions, and various governmental agencies. Magellan Health Services, Inc. was founded in 1969 and is based in Avon, Connecticut.

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market was quiet on Wednesday, with different benchmarks reacting to a variety of news events. The release of minutes from the Federal Reserve’s most recent monetary policy meeting generally confirmed what most investors had believed about the central bank’s future course of action, and that helped send the Dow Jones Industrial Average and the S&P 500modestly higher. Yet weakness in key technology stocks caused the Nasdaq Composite to lag its peers. Several stocks posted strong advances, and Garmin (NASDAQ:GRMN), Kandi Technologies Group (NASDAQ:KNDI), and Magellan Health (NASDAQ:MGLN) were among the top performers. Here’s why they did so well.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Magellan Health (MGLN)

    For more information about research offerings from Zacks Investment Research, visit

Hot Value Stocks To Own For 2021: Horizon Global Corporation(HZN)

Horizon Global Corporation, incorporated on January 14, 2015, is a designer, manufacturer and distributor of a range of custom-engineered towing, trailering, cargo management and other related accessory products serving the automotive aftermarket, retail and original equipment (OE) channels. The Company operates through two segments: Cequent Americas and Cequent APEA. The Company’s Cequent Americas and Cequent APEA marketed through original equipment manufacturers (OEMs), OE suppliers, retailers and aftermarket customers servicing users in the agricultural, automotive, construction, horse/livestock, industrial, marine, military, recreational, trailer and utility markets. Its products are used in approximately two primary categories across the world, including commercial applications (Work) and recreational activities (Play). The markets in its Work category include agricultural, automotive, construction, fleet, industrial, marine, military, mining and municipalities. The markets in its Play category include equestrian, power sports, recreational vehicle, specialty automotive, truck accessory and other specialty towing applications. The Company distributes its products through independent installers, warehouse distributors, dealers, OE, retail stores and online retailers.

The Company’s brands include Reese, Hayman-Reese, Draw-Tite, Aqua Clear, Bulldog, BTM, DHF, Engetran, Fulton, Harper, Hidden Hitch, Highland, Kovil, Laitner, Parkside, Pro Series, Reese Secure, Reese Explorer, Reese Power Sports, Reese Towpower, ROLA, Tekonsha, Trojan, WesBarg and Witter Towbar System. The Company has over 6,700 customers across the world. The Company operates manufacturing facilities in Australia, Brazil, Germany, Mexico, New Zealand, South Africa, Thailand and the United Kingdom.

Cequent Americas

The Cequent Americas segment consists of two operating segments: Cequent Performance Products (CPP), a manufacturer of aftermarket and OEM towing and trailering products and accessorie! s, and Cequent Consumer Products (CCP), a provider of towing, trailering, vehicle protection and cargo management solutions serving the end user through retailers. The Cequent Americas segment has operations in North America, and its towing and trailering-related products are sold through retail, aftermarket and OE channels.

Cequent APEA

The Cequent APEA segment focuses its sales and manufacturing efforts outside of the Americas, operating in Australia. The Company also operates in New Zealand, Thailand, Europe, the United Kingdom, South Africa, Germany and Asia Pacific region. It is in the early-stages of its development in these markets focusing on supporting OE customers.

The Company competes with Curt Manufacturing, B&W Trailer Hitches, The Bosal Group, Brink, Westfalia, Buyers Products Company, Demco Products, PullRite, Westin Automotive Products, Camco, Pacific Rim, Dutton-Lainson, Shelby, Ultra-Fab, Sea-Sense, Atwood, Thule, Yakima, Bell, Masterlock and Saris.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Horizon Global (HZN)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Horizon Global (HZN)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Brian Feroldi]

    Horizon Global(NYSE:HZN)reported its second-quarter results on Aug. 7th. Investors had already been provided with a sneak peek at the towing and trailering company’s results in mid-July after management announced that it was expanding its ability to borrow by $50 million. The company’s second-quarter results were largely in line with those updated projections, and management reaffirmed that its turnaround remains on track. However, the year-over-year numbers did not look pretty.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of Horizon Global (NYSE:HZN) from a strong sell rating to a sell rating in a research note released on Wednesday.

    A number of other research firms have also commented on HZN. Zacks Investment Research raised Horizon Global from a strong sell rating to a hold rating in a research report on Thursday, March 29th. B. Riley assumed coverage on Horizon Global in a research report on Friday, April 13th. They issued a buy rating and a $12.50 price target for the company. Bank of America lowered Horizon Global from a buy rating to an underperform rating and lowered their price target for the company from $10.00 to $5.00 in a research report on Friday, June 22nd. Finally, Roth Capital increased their price target on Horizon Global from $6.50 to $7.50 and gave the company a neutral rating in a research report on Friday, June 22nd. Four equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average price target of $13.86.

Leave a Reply

Your email address will not be published. Required fields are marked *